Robert J Delaversano's Net Worth
$24 Thousand
Who is Robert J Delaversano?
Robert J Delaversano does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include U.S. GOLD CORP., ONCOSEC MEDICAL Inc, and Acasti Pharma Inc..
SEC CIK
Robert J Delaversano's CIK is 0001728262
Past Insider Trading and Trends
2020 was Robert J Delaversano's most active year for acquiring shares with 3 total transactions. Robert J Delaversano's most active month to acquire stocks was the month of April. 2022 was Robert J Delaversano's most active year for disposing of shares, totalling 4 transactions. Robert J Delaversano's most active month to dispose stocks was the month of April. 2020 saw Robert J Delaversano paying a total of $0.00 for 106,416 shares, this is the most they've acquired in one year. In 2020 Robert J Delaversano cashed out on 8,679 shares for a total of $19,354.17, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
U.S. GOLD CORP. (USAU) Snapshot price: $5.36
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ONCOSEC MEDICAL Inc (ONCSQ) Snapshot price: $0.000001
VP, FinanceRobert J Delaversano owns 1,008 units of Common Stock which is worth $0.00. In the year 2020 Robert J Delaversano filed a total of 13 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.82% | -40.00 |
$1.37 | -$54.80 | 1.01K |
Feb 9
| |||
Form 4
| -1.22% | -283.00 |
$0.37 | -$104.71 | 22.98K |
Nov 4
| |||
Form 4
| -1.21% | -284.00 |
$0.71 | -$201.64 | 23.26K |
Aug 5
| |||
Form 4
| -1.15% | -274.00 |
$0.83 | -$227.42 | 23.54K |
May 6
| |||
Form 4
| -1.69% | -409.00 |
$0.88 | -$359.92 | 23.82K |
Feb 9
| |||
Form 4
| -1.40% | -343.00 |
$1.75 | -$600.25 | 24.23K |
Nov 1
| |||
Form 4
| -1.65% | -412.00 |
$2.18 | -$898.16 | 24.57K |
Aug 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
| -1.78% | -453.00 |
$4.86 | -$2,201.58 | 24.98K |
May 3
| |||
Form 4
| +52.45% | 8.75K |
—
|
—
| 25.43K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 24
| |||
Form 4
|
∞
| 16.68K |
$2.23 | -$19,354.17 | 16.68K |
May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Acasti Pharma Inc. (ACST) Snapshot price: $2.51
Principal Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||